TCT 464: A Novel Approach to Treat and Reverse Moderate/Servere Heart Failure to NYHA I-II Using Direct Electrical Microcurrent Receive the the latest news, research, and presentations from major ...
The 2024 edition of Transcatheter Cardiovascular Therapeutics (TCT) once again highlighted significant innovations in ...
Heartwire from Medscape, September 28, 2009 TCT CURRENT OASIS 7 PCI Analysis Doubling the dose of clopidogrel reduced the risk of MI and stent thrombosis in STEMI patients without increasing the ...
By Katherine Schulten Weekly Student News Quiz: Election Day, World Series, Floods Have you been paying attention to current events recently? See how many of these 10 questions you can get right.
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
The inability of QFR to rival FFR for 1-year MACE is a reminder of the need for large studies, even when new tech is enticing ...
The U.S. hasn’t updated its own alcohol warning labels in 35 years — despite the fact that we’ve learned a lot since then ...
In older people with asymptomatic severe aortic stenosis (AS) and preserved left ventricular ejection fraction (LVEF), ...
According to Dangas, the trial set a "very high bar" for early heparin to succeed: it had to show benefit on top of the "very ...
The ECLIPSE trial, presented as a late-breaking study at the Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics (TCT) conference in Washington, D.C., had enrolled ...
The San Antonio Current, San Antonio's award-winning alternative media company, has served as the city's premiere multimedia source of alternative news, events and culture since 1986. We dig deep ...